Results 121 to 130 of about 421,015 (257)
ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein +7 more
wiley +1 more source
Effect of specific and sensitive interventions for the social protection of people affected by tuberculosis: a meta-analysis. [PDF]
Ferreira MRL +5 more
europepmc +1 more source
Social protection reform in Morocco in the aftermath of COVID-19. [PDF]
Mansour HA, Benmouro Y.
europepmc +1 more source
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund +3 more
wiley +1 more source
Social protection as a right of people affected by tuberculosis: a scoping review and conceptual framework. [PDF]
Ferreira MRL +8 more
europepmc +1 more source
ABSTRACT Objective Status epilepticus (SE) is associated with significant mortality. Sleep architecture may reflect normal brain function. Impaired sleep architecture is associated with poorer outcomes in numerous conditions. Here we investigate the association of sleep architecture in continuous EEG (cEEG) with survival in SE.
Ran R. Liu +5 more
wiley +1 more source
Exploring access to social protection by persons with disabilities in Bangladesh. [PDF]
Rahman M, Rana MS, Rahman MM, Khan MN.
europepmc +1 more source
A model for integrating social protection measures with TB control in Pakistan. [PDF]
Habib SS, Uzair M, Dhanwani A, Sohail K.
europepmc +1 more source
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein +13 more
wiley +1 more source

